To assess the capability of magnetic resonance imaging (MRI) to define
the presence, degree, and distribution of apical hypertrophic cardiom
yopathy in patients of European descent, MRI examination was prospecti
vely performed in patients diagnosed with hypertrophic cardiomyopathy
on two-dimensional echocardiography. Twenty-five patients with hypertr
ophy located exclusively at the cardiac apex were the object of this s
tudy. Spin echo and gradient echo sequences were performed to evaluate
the morphology, motility, and myocardial thickness of the left ventri
cle in diastole. In a short-axis gradient echo sequence from base to a
pex, septal, lateral, anterior, and posterior segments at the basal an
d apical levels were measured. A four-chamber view and horizontal long
-axis images of the left ventricle were performed to measure the true
apex. A concentric, symmetric distribution of hypertrophic myocardium
was considered when the thickness was 1.5 cm or greater, with the four
segments being affected to a similar degree. Asymmetric hypertrophy w
as considered when the wall thickness ratio was more than 1.3. Myocard
ial thicknesses at the apical level were 2.03 +/- 0.60 cm (mean +/- st
andard deviation) at the true apex; the septal thickness was 1.19 +/-
0.46 cm; lateral, 1.62 +/- 0.71 cm; anterior, 1.36 +/- 0.57 cm; and po
sterior, 1.28 +/- 0.53 cm. Based on the MRI findings, the distribution
of apical hypertrophy was classified as symmetric (n = 2), asymmetric
(n = 18), and true apex (n = 5). A spadelike configuration of the lef
t ventricle was observed in only five cases. MRI demonstrates that in
Western patients the morphologic spectrum of apical hypertrophy cardio
myopathy is quite wide and includes myocardial hypertrophy exclusively
localized at the true apex.